IRulya Therapeutics Inc. SEC filings IRLA
IRulya Therapeutics Inc. has 462 filings in SEC EDGAR's recent list, going back to Jan 5, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 19, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Oct 9, 2026 | Oct 7, 2026 |
| S-8 | Employee stock plan registration | Oct 8, 2026 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Oct 6, 2026 | Oct 6, 2026 |
| DEFA14A | Additional proxy material | Oct 2, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change
|
Sep 14, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 4, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2026 | Aug 23, 2026 |
| DEF 14A | Proxy statement | Aug 25, 2026 | Oct 6, 2026 |
| EFFECT | Filing | Aug 24, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| S-3/A | Filing | Aug 5, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jul 31, 2026 | Jul 29, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 31, 2026 | Jul 31, 2026 |
| S-3 | Shelf registration | Jul 31, 2026 | — |
| 8-K/A |
Amended current report
Other events
|
Jul 30, 2026 | May 17, 2026 |
| 8-K/A |
Amended current report
Change to shareholder rights
|
Jun 26, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jun 26, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| D | Filing | Jun 11, 2026 | — |
| D | Filing | Jun 11, 2026 | — |
| 8-K |
Current report
Other events
|
May 21, 2026 | May 20, 2026 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
May 18, 2026 | May 17, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
May 18, 2026 | May 17, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
Apr 28, 2026 | Apr 27, 2026 |
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2026 | Apr 22, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Jun 11, 2026 |
| S-8 | Employee stock plan registration | Apr 17, 2026 | — |
| 10-K | Annual report | Apr 10, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Apr 9, 2026 | Apr 9, 2026 |
| NT 10-K | Filing | Apr 1, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Mar 30, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 20, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Other events
|
Jan 29, 2026 | Jan 29, 2026 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 17, 2025 | Oct 17, 2025 |
| 424B5 | Prospectus supplement | Oct 17, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Sep 26, 2025 | Sep 25, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| EFFECT | Filing | Aug 5, 2025 | — |
| 424B5 | Prospectus supplement | Aug 5, 2025 | — |
| CORRESP | Letter to the SEC | Aug 1, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2025 | — |
| S-3 | Shelf registration | Jul 25, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 16, 2025 | Jul 16, 2025 |
| D | Filing | Jul 1, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 4, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Jun 4, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 9, 2025 | Dec 31, 2024 |
| S-8 | Employee stock plan registration | Mar 24, 2025 | — |
| 424B5 | Prospectus supplement | Mar 24, 2025 | — |
| 10-K | Annual report | Mar 24, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2025 | Mar 24, 2025 |
| 424B5 | Prospectus supplement | Dec 27, 2024 | — |
| EFFECT | Filing | Dec 26, 2024 | — |
| CORRESP | Letter to the SEC | Dec 23, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2024 | — |
| S-3 | Shelf registration | Dec 18, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 14, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 5, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2024 | Jun 5, 2024 |
| S-8 | Employee stock plan registration | Apr 1, 2024 | — |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 15, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 29, 2024 | Jan 23, 2024 |
| 8-K/A | Amended current report | Jan 5, 2024 | Oct 20, 2023 |
| 8-K |
Current report
Other events
|
Jan 3, 2024 | Dec 29, 2023 |
| 8-K |
Current report
Agreement ended
|
Dec 22, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 8, 2023 | Dec 4, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 26, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Officer or director change
|
Oct 23, 2023 | Oct 20, 2023 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change
|
Sep 6, 2023 | Aug 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 10, 2023 | Aug 4, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Jul 24, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 25, 2023 | May 24, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 14, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 14, 2023 | — |
| DEF 14A | Proxy statement | Apr 14, 2023 | — |
| 8-A12B | Filing | Apr 5, 2023 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Apr 5, 2023 | Apr 5, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2023 | Mar 27, 2023 |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| 10-K | Annual report | Mar 15, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Other events
|
Jan 30, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jan 27, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 16, 2022 | Dec 13, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2022 | Sep 28, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Bylaw or fiscal year change, Other events
|
Aug 1, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2022 | Jul 20, 2022 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change, Shareholder vote results
|
Jun 10, 2022 | Jun 8, 2022 |
| DEFA14A | Additional proxy material | May 25, 2022 | — |
| S-8 | Employee stock plan registration | May 20, 2022 | — |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change
|
May 20, 2022 | May 19, 2022 |
| 424B5 | Prospectus supplement | May 19, 2022 | — |
| EFFECT | Filing | May 17, 2022 | — |
| POS EX | Filing | May 17, 2022 | — |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Officer or director change
|
May 12, 2022 | May 7, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Other events
|
May 10, 2022 | May 9, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
May 2, 2022 | Apr 26, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 15, 2022 | Mar 14, 2022 |
| POS AM | Filing | Mar 4, 2022 | — |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| POSASR | Filing | Feb 7, 2022 | — |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Other events
|
Feb 2, 2022 | Jan 28, 2022 |
| 8-K |
Current report
Other events
|
Jan 26, 2022 | Jan 25, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 23, 2021 | Dec 23, 2021 |
| 424B5 | Prospectus supplement | Dec 23, 2021 | — |
| 10-Q | Quarterly report | Oct 29, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Other events
|
Oct 26, 2021 | Oct 26, 2021 |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
May 18, 2021 | May 13, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 16, 2021 |
| S-8 | Employee stock plan registration | Mar 1, 2021 | — |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Other events
|
Feb 16, 2021 | Feb 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 10, 2021 | Feb 9, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 26, 2021 | Jan 26, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 25, 2021 | Jan 19, 2021 |
| 8-K |
Current report
Other events
|
Dec 4, 2020 | Dec 4, 2020 |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2020 | Jun 8, 2020 |
| S-3ASR | Automatic shelf registration | Jun 1, 2020 | — |
| 8-K |
Current report
Officer or director change
|
May 21, 2020 | May 18, 2020 |
| 8-K |
Current report
Results of operations
|
May 12, 2020 | May 12, 2020 |
| 10-Q | Quarterly report | May 12, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2020 | Apr 27, 2020 |
| DEFA14A | Additional proxy material | Apr 22, 2020 | — |
| DEF 14A | Proxy statement | Apr 22, 2020 | Jun 8, 2020 |
| EFFECT | Filing | Apr 13, 2020 | — |
| 424B3 | Prospectus | Apr 13, 2020 | — |
| CORRESP | Letter to the SEC | Apr 9, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2020 | — |
| S-1 | Registration statement | Apr 7, 2020 | — |
| 8-K |
Current report
Results of operations
|
Mar 17, 2020 | Mar 17, 2020 |
| S-8 | Employee stock plan registration | Mar 16, 2020 | — |
| 10-K | Annual report | Mar 16, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 6, 2020 | Feb 5, 2020 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 9, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | Jun 12, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
May 13, 2019 | May 13, 2019 |
| 424B4 | Prospectus | May 9, 2019 | — |
| S-8 | Employee stock plan registration | May 9, 2019 | — |
| EFFECT | Filing | May 8, 2019 | — |
| CORRESP | Letter to the SEC | May 6, 2019 | — |
| CORRESP | Letter to the SEC | May 6, 2019 | — |
| CERT | Filing | May 6, 2019 | — |
| 8-A12B | Filing | May 1, 2019 | — |
| CORRESP | Letter to the SEC | Apr 29, 2019 | — |
| CORRESP | Letter to the SEC | Apr 29, 2019 | — |
| S-1/A | Amended registration statement | Apr 29, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2019 | — |
| S-1/A | Amended registration statement | Apr 16, 2019 | — |
| CORRESP | Letter to the SEC | Apr 12, 2019 | — |
| S-1 | Registration statement | Apr 12, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 2, 2019 | — |
| DRS | Filing | Mar 4, 2019 | — |
| D | Filing | May 31, 2018 | — |
| D | Filing | Feb 14, 2017 | — |
| D | Filing | Jan 5, 2016 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IRLA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1662774
- Former names
- Quince Therapeutics, Inc. (until Oct 9, 2026); Cortexyme, Inc. (until Aug 1, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.